Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00515359 · ClinicalTrials.gov registry record · NA

RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies

A NA study of Encephalopathy and Developmental Delay and Behavioral Changes, sponsored by Corewell Health West.

Completed
Registry status
NA
Development phase
276
Enrollment target
1
Study location

NCT00515359 is a NA study of Encephalopathy and Developmental Delay and Behavioral Changes that has completed, run by Corewell Health West. The registered enrollment target is 276 participants, above the 175-participant average among 7 other Encephalopathy trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00515359, a NA study of Encephalopathy and Developmental Delay and Behavioral Changes, has completed, sponsored by Corewell Health West.

COMPLETED
Registry status
NA
Development phase
276 participants
Enrollment target
1
Study location

Study Summary

RCT for Intermittent versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies

Interventions

  • PROCEDURE Intermittent Propofol Sedation
  • PROCEDURE Continuous Propofol Sedation

Study Locations (1)

Michigan

  • Spectrum Health - Grand Rapids

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2007-06
Est. Completion 2009-02
Phase NA

Sponsor

Corewell Health West

38 total trials

What the Registry Record Tells You About NCT00515359

The ClinicalTrials.gov registry entry for NCT00515359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 175-participant average among 7 other Encephalopathy trials with a reported enrollment target (58% higher). The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Encephalopathy appearing as the primary indexed condition, and to 2 interventions - of which Intermittent Propofol Sedation is the first listed.

NCT00515359 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT00515359 about?

NCT00515359 is a clinical study titled "RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies". RCT for Intermittent versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies

What is the current status of trial NCT00515359?

This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2007-06. Estimated completion is 2009-02.

What conditions does trial NCT00515359 study?

This clinical trial studies the following conditions: Encephalopathy, Developmental Delay and Behavioral Changes, Cord Tumor Compression or Instability, Cord Tethering or Malformation.

What interventions are being tested in trial NCT00515359?

The interventions under investigation include: Intermittent Propofol Sedation (PROCEDURE), Continuous Propofol Sedation (PROCEDURE).

Who is sponsoring clinical trial NCT00515359?

This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00515359 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Encephalopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.